Strong results from preventive use of ColdZyme against common cold virus
Enzymatica is now disclosing a report based on four user surveys from the years 2015 to 2019 concerning use of ColdZyme to prevent common colds. Almost half of the respondents answered that use of ColdZyme before common cold symptoms arise results in fewer colds. Since the respondents began using ColdZyme preventively almost 3 of 4 felt that their colds were milder, with fewer sick days as a result.Enzymatica commissioned the market research company Gfk/IPSOS to compile four previous user surveys from 2015 to 2019 regarding use of ColdZyme. A total of 805 individuals were included in the